June 28, 2018 – The American Food and Drug Administration (FDA), a couple of week ago, approved Erenumab-Aooe (Aimovig) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Erenumab-Aooe (Aimovig) is the first FDA-approved …

Erenumab-Aooe (Aimovig): Novel preventive treatment for migraine approved Read more »

April 13, 2014 – The American Food and Drug Administration (FDA) has issued a new Boxed Warning for Valproic Acid [Stavzor] and its association with drug induced liver disease (hepatotoxicity, hepatic failure) which may be fatal in some patients. We …

Valproic Acid [Stavzor]: Newly issued boxed warning for life-threatening liver disease Read more »